Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -1407.52% is 599% below its 5-year average of -201.49%, near the high end of its 5-year range (-10144001.41%–0.00%).
118.30% below its 12-month average of -644.76%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
-1407.52%
OPERATING MARGIN AVG TTM
-644.76%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
-201.49%
OPERATING MARGIN AVG 10Y
-110.89%
OPERATING MARGIN AVG 15Y
-130.76%
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-118.30%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
-598.57%
CURRENT VS 10Y AVG
-1169.25%
CURRENT VS 15Y AVG
-976.45%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Crescent Biopharma, Inc.
Market Cap
$510.36M
Operating Margin
-1407.52%
TTM Avg
-644.76%
3Y Avg
0.00%
5Y Avg
-201.49%
Market Cap
$509.12M
Operating Margin
-46.01%
TTM Avg
-85.84%
3Y Avg
-83.08%
5Y Avg
-67.71%
Market Cap
$509.10M
Operating Margin
0.00%
TTM Avg
-620906.82%
3Y Avg
-450471.78%
5Y Avg
-300340.85%
Market Cap
$520.33M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$500.30M
Operating Margin
10.00%
TTM Avg
8.23%
3Y Avg
4.46%
5Y Avg
2.51%
Market Cap
$522.16M
Operating Margin
-230460.98%
TTM Avg
-373160.49%
3Y Avg
-159952.53%
5Y Avg
-107112.87%
Market Cap
$523.04M
Operating Margin
-975.91%
TTM Avg
-867.04%
3Y Avg
-586.91%
5Y Avg
-743.36%
Market Cap
$497.66M
Operating Margin
0.00%
TTM Avg
-5335.57%
3Y Avg
-2667.78%
5Y Avg
-1778.52%
Market Cap
$526.07M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Crescent Biopharma, Inc. (CBIO) | $510.36M | -1407.52% | -644.76% | 0.00% | -201.49% |
| 908 Devices Inc. (MASS)vs › | $509.12M | -46.01% | -85.84% | -83.08% | -67.71% |
| Allogene Therapeutics, Inc. (ALLO)vs › | $509.10M | 0.00% | -620906.82% | -450471.78% | -300340.85% |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $520.33M | 0.00% | 0.00% | 0.00% | 0.00% |
| Tactile Systems Technology, Inc. (TCMD)vs › | $500.30M | 10.00% | 8.23% | 4.46% | 2.51% |
| Altimmune, Inc. (ALT)vs › | $522.16M | -230460.98% | -373160.49% | -159952.53% | -107112.87% |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $523.04M | -975.91% | -867.04% | -586.91% | -743.36% |
| Oculis Holding AG (OCS)vs › | $497.66M | 0.00% | -5335.57% | -2667.78% | -1778.52% |
| Immix Biopharma, Inc. (IMMX)vs › | $526.07M | 0.00% | 0.00% | 0.00% | 0.00% |
| Puma Biotechnology, Inc. (PBYI)vs › | $489.65M | 13.16% | 14.88% | 13.50% | 6.84% |
Gross Margin
100.0%
Operating Margin
-1407.5%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | -2380.08% |
| 2025-12-31 | -843.71% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | -95908.34% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | -17804.21% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | -98870.20% |
| 2021-09-30 | -20028.82% |
| 2021-06-30 | -10144001.41% |
| 2021-03-31 | -1352.98% |
| 2020-12-31 | -9554.94% |
| 2020-09-30 | -1372.73% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | -90.09% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | -42631.11% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | -25123.75% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 51.84% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 53.66% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | -4988.95% |
| 2013-09-30 | -7039.81% |
| 2013-06-30 | -6349.56% |
| 2013-03-31 | 12.05% |
| 2012-12-31 | 16.49% |
| 2012-09-30 | 21.53% |
